Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hgns: Metabolic Endpoints For Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation

NCT06317701 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT06317701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06317701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hgns: Metabolic Endpoints For Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation
Lead sponsor
University of Chicago
Phase
Observational
Overall status
Recruiting
Start date
April 4, 2024
Completion date
April 30, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea